The importance of this system in bone metabolism is demonstrated by the fact that pharmacologic blockade of RANKL is an effective treatment for osteoporosis [19], that an inherited deficiency of RANK or RANKL causes osteopetrosis, and that loss-of-function OPG mutations cause juvenile Paget's disease [20, 21]. The gene discussed is TNFRSF11A; the disease is osteoporosis.